Kvælstofforiltes smertestillende effekt ved tandbehandling af børn

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2009-009917-16-DK

Enrollment

Registered

2009-02-09

Start date

2009-03-25

Completion date

Unknown

Last updated

2021-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kvælstofforiltes analgetiske effekt ved tandbehandling af børn MedDRA version: 9.1 Level: LLT Classification code 10052803 Term: Analgesic effect

Interventions

Trade Name: Niontix Pharmaceutical Form: Inhalation gas Other descriptive name: Niontix Pharmaceutical form of the placebo: Inhalation gas Route of administration of the placebo: Inhalation use

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Raske børn i alderen 12 - 15 år Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: ingen

Design outcomes

Primary

Measure	Time frame
Main Objective: Måle smerte på tand, muskel og hud ved inhalation af Niontix;Secondary Objective: ;Primary end point(s): Kvælstofforiltes analgetiske effekt ved smerte på tand, muskel og hud	—

Countries

Denmark

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026